Evaluating the Validity of a Novel Transgenic Mouse Model for Neuregulin 1 Type III for Schizophrenia

被引：0
|
作者：
Karl, Tim [1 ]
机构：
[1] Neurosci Res Australia, Randwick, NSW, Australia
来源：
NEUROPSYCHOPHARMACOLOGY | 2015年 / 40卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
37.2
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] Schizophrenia-like phenotypes of a novel transgenic mouse model for neuregulin-1 type III
    Olaya, J.
    Heusner, C.
    Matsumoto, M.
    Karl, T.
    Weickert, C. S.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 353 - 353
  • [2] Effects of handling on the behavioural phenotype of the neuregulin 1 type III mouse model for
    Guerra, Stefan
    Chesworth, Rose
    Weickert, Cynthia Shannon
    Karl, Tim
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2021, 405
  • [3] CANNABINOIDS: RISK FACTORS FOR A NEUREGULIN 1 MOUSE MODEL OF SCHIZOPHRENIA?
    Karl, Tim
    Boucher, A.
    Chesworth, R.
    Long, Leonora Elizabeth
    Arnold, J.
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 71 - 72
  • [4] The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
    Visini, Gabriela
    Brown, Samara
    Weston-Green, Katrina
    Shannon Weickert, Cynthia
    Chesworth, Rose
    Karl, Tim
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [5] CANNABINOIDS: ENVIRONMENTAL RISK FACTORS FOR A NEUREGULIN 1 MOUSE MODEL FOR SCHIZOPHRENIA?
    Karl, Tim
    Chesworth, Rose
    Arnold, Jonathon
    Long, Leonora
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 390 - 391
  • [6] Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy
    Belin, S.
    Ornaghi, F.
    Shackleford, G.
    Bansal, R.
    Schwab, M. H.
    Nave, K.
    Frattra, P.
    D'Antonio, M.
    Poitelon, Y.
    Feltri, M. L.
    Wrabetz, L.
    [J]. GLIA, 2019, 67 : E447 - E448
  • [7] Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy
    Belin, Sophie
    Ornaghi, Francesca
    Shackleford, Ghjuvan Ghjacumu
    Wang, Jie
    Scapin, Cristina
    Lopez-Anido, Camila
    Silvestri, Nicholas
    Robertson, Neil
    Williamson, Courtney
    Ishii, Akihiro
    Taveggia, Carla
    Svaren, John
    Bansal, Rashmi
    Schwab, Markus H.
    Nave, Klaus
    Fratta, Pietro
    D'Antonio, Maurizio
    Poitelon, Yannick
    Feltri, M. Laura
    Wrabetz, Lawrence
    [J]. HUMAN MOLECULAR GENETICS, 2019, 28 (08) : 1260 - 1273
  • [8] GENETIC EXPRESSION FOLLOWING NEUREGULIN 1 β DEFICIENCY IN A MOUSE MODEL OF SCHIZOPHRENIA BIOLOGY
    Pulliam, John V. K.
    Ford, G.
    Ford, B.
    Xu, Z.
    Tewolde, T.
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 75 - 75
  • [9] CANNABIDIOL AS A POTENTIAL PREVENTATIVE TREATMENT IN A NEUREGULIN-1 MOUSE MODEL OF SCHIZOPHRENIA
    Visini, Gabriela
    Chesworth, Rose
    Karl, Tim
    [J]. SCHIZOPHRENIA BULLETIN, 2020, 46 : S298 - S299
  • [10] TRANSGENIC OVEREXPRESSION OF THE TYPE III ISOFORM OF NEUREGULIN 1 IN MICE INDUCES ABNORMALITIES ON AUDITORY EVENT RELATED EEG BIOMARKERS RELATED TO SCHIZOPHRENIA
    Rosenbrock, Holger
    Nissen, Wiebke
    Arban, Roberto
    Moritz, Rossner
    Markus, Schwab
    Dorner-Ciossek, Cornelia
    Schuelert, Niklas
    [J]. SCHIZOPHRENIA BULLETIN, 2018, 44 : S380 - S380
12345